Augmentation of kallikrein and plasmin inhibition capacity by aprotinin using a new assay to monitor therapy.
Gallimore
M J
MJ
Dept. of Cardiovascular Surgery, University of Tuebingen, FRG.
Fuhrer
G
G
Heller
W
W
Hoffmeister
H E
HE
D007611:Aprotinin / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D006801:Humans; D007610:Kallikreins / Q000097:blood*; D007700:Kinetics; D008991:Monitoring, Physiologic
D007611:Aprotinin; D007610:Kallikreins; D005341:Fibrinolysin